SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Cell Therapy Manufacturing Services Agreement With Adaptimmune Ltd.